| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 31 |
| 1 | BISOPROLOL FUMARATE | 17 |
| 2 | SPIRONOLACTONE | 13 |
| 3 | IBUPROFEN | 11 |
| 4 | FUROSEMIDE | 10 |
| 5 | IBUPFROFEN | 10 |
| 6 | IBUPROFEN 200 MG | 10 |
| 7 | IBUPROFEN 200MG | 10 |
| 8 | IBUPROFEN CAPSULE | 10 |
| 9 | IBUPROFEN CAPSULES 200 MG | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFPROZIL | 1 | 0.0013 |
| 1 | SOTALOL HYDROCHLORIDE TABLES AF | 2 | 0.0008 |
| 2 | SOTALOL HYDROCHLORIDE TABLETS AF | 2 | 0.0008 |
| 3 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | 2 | 0.0008 |
| 4 | SENNOSIDES A AND B | 1 | 0.0006 |
| 5 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 8 | 0.0006 |
| 6 | EDOXABAN TOSYLATE | 4 | 0.0006 |
| 7 | ESTAZOLAM | 1 | 0.0005 |
| 8 | DAPRODUSTAT | 1 | 0.0005 |
| 9 | NERATINIB | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 35 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 19 |
| 2 | Aldosterone Antagonist [EPC] | 17 |
| 3 | Platinum-based Drug [EPC] | 14 |
| 4 | Loop Diuretic [EPC] | 12 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 10 |
| 6 | Thiazide Diuretic [EPC] | 10 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 9 |
| 8 | beta-Adrenergic Blocker [EPC] | 8 |
| 9 | Endothelin Receptor Antagonist [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Parenteral Iron Replacement [EPC] | 2 | 0.0001 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 2 | 0.0001 |
| 3 | Factor Xa Inhibitor [EPC] | 35 | 0.0001 |
| 4 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 5 | Aldosterone Antagonist [EPC] | 17 | 0.0001 |
| 6 | Cholinesterase Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Erythropoiesis-stimulating Agent [EPC] | 5 | 0.0001 |
| 8 | Nitrate Vasodilator [EPC] | 7 | 0.0001 |
| 9 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |